Cargando…
A novel biologically hierarchical hydrogel with osteoblast precursor‐targeting extracellular vesicles ameliorates bone loss in vivo via the sequential action of antagomiR‐200b‐3p and antagomiR‐130b‐3p
Osteoporotic fracture is a major health problem plaguing the ageing society, and improving its treatment is an urgent challenge. How to ameliorate bone loss determines the recovery of such fractures. Extracellular vesicle (EV)‐loaded hydrogel has the capacity to treat osteoporotic fractures due to i...
Autores principales: | Dai, Hanhao, Yu, Yunlong, Han, Junyong, Luo, Jun, Song, Chao, Deng, Zhibo, Wu, Yijing, Ke, Dianshan, Xu, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10392057/ https://www.ncbi.nlm.nih.gov/pubmed/36786008 http://dx.doi.org/10.1111/cpr.13426 |
Ejemplares similares
-
Therapeutic Potential of AntagomiR-23b for Treating Myotonic Dystrophy
por: Cerro-Herreros, Estefanía, et al.
Publicado: (2020) -
AntagomiR-103 and -107 Treatment Affects Cardiac Function and Metabolism
por: Rech, Monika, et al.
Publicado: (2018) -
Potential therapeutic role of antagomiR17 for the treatment of chronic lymphocytic leukemia
por: Dereani, Sara, et al.
Publicado: (2014) -
Preclinical characterization of antagomiR-218 as a potential treatment for myotonic dystrophy
por: Cerro-Herreros, Estefanía, et al.
Publicado: (2021) -
AntagomiR‐29b inhibits vascular and valvular calcification and improves heart function in rats
por: Fang, Ming, et al.
Publicado: (2020)